Imeroprubart

8 trials 6 recruiting

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

6 Recruiting

2 Completed trials

1 Sponsors

21 Countries

Phase III

Phase II

Phase III: 1 Phase II: 7

Sponsors using this IMP

Immunovant Sciences GmbH 8

All trials

8 total

A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease Recruiting

2025-524001-33-00 Phase II 11 countries Immunovant Sciences GmbH
Efficacy and Safety of IMVT-1402 in Adult Participants with Primary Sjogren’s Disease with Moderate to Severe Systemic Disease Activity Recruiting

2025-520831-18-00 Phase II 7 countries Immunovant Sciences GmbH
A Phase 2b Study of IMVT-1402 Treatment in CIDP Recruiting

2024-517614-14-00 Phase II 19 countries Immunovant Sciences GmbH
A Phase 2b Study to Assess the Efficacy and Safety of IMVT-1402 in Patients With Graves' Disease Recruiting

2025-521920-31-00 Phase II 9 countries Immunovant Sciences GmbH
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis Recruiting

2024-515979-35-00 Phase III 9 countries Immunovant Sciences GmbH
A Phase 2b Study to Assess the Efficacy and Safety of IMVT-1402 in Patients with Grave’s Disease Recruiting

2024-516020-33-00 Phase II 6 countries Immunovant Sciences GmbH
A Phase 2b Study to Assess IMVT-1402 in Participants with Cutaneous Lupus Erythematosus Ended

2024-516745-39-00 Phase II 5 countries Immunovant Sciences GmbH
A Phase 2b to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With ACPA-Positive Rheumatoid Arthritis Ended

2024-515973-82-00 Phase II 7 countries Immunovant Sciences GmbH

Showing 1–8 of 8 trials

← All drugs A–Z